Tin tức & Cập nhật

Vebicorvir plus entecavir safe, effective in chronic HBV patients
Vebicorvir plus entecavir safe, effective in chronic HBV patients
03 Nov 2022 bởiStephen Padilla

The addition of vebicorvir to entecavir in treatment-naïve patients with chronic hepatitis B virus (HBV) infection provides further antiviral activity, with a positive safety and tolerability profile, results of a phase II trial have shown.

Vebicorvir plus entecavir safe, effective in chronic HBV patients
03 Nov 2022
Serum cholesterol efflux capacity underpins early AMD
Serum cholesterol efflux capacity underpins early AMD
03 Nov 2022 bởiTristan Manalac

Patients with early age-related macular degeneration (eAMD) appear to have increased serum cholesterol efflux capacity, according to a recent Singapore study. The same is true for polypoidal choroidal vasculopathy (PCV), but not for typical neovascular AMD (tAMD).

Serum cholesterol efflux capacity underpins early AMD
03 Nov 2022
Extended-release nifedipine benefits women with severe pre-eclampsia
Extended-release nifedipine benefits women with severe pre-eclampsia
02 Nov 2022
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022 bởiJairia Dela Cruz

Patients with concomitant chronic kidney disease (CKD) and type 2 diabetes (T2D) who are undergoing mineralocorticoid receptor blockade with finerenone are better protected against pneumonia and COVID-19, according to a secondary analysis of data from the FIDELITY trials.

Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022